These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34623932)

  • 21. Utility of serological screening for measles, mumps and rubella in immunocompromised patients.
    Sticchi L; Astengo M; Iavarone IG; Icardi G
    Hum Vaccin Immunother; 2019; 15(12):2854-2855. PubMed ID: 31442102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996.
    dos Santos BA; Stralioto SM; Siqueira MM; Ranieri TS; Bercini M; Schermann MT; Wagner MB; Silveira TR
    Rev Panam Salud Publica; 2006 Nov; 20(5):299-306. PubMed ID: 17316487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants.
    Malshe N; Palkar S; Kulkarni R; Lalwani S; Mishra AC; Arankalle V
    Vaccine; 2019 Mar; 37(11):1443-1448. PubMed ID: 30765170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C; Mankertz A
    PLoS One; 2012; 7(8):e42867. PubMed ID: 22880124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
    Nicoara C; Zäch K; Trachsel D; Germann D; Matter L
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):868-71. PubMed ID: 10548578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.
    Domínguez A; Plans P; Costa J; Torner N; Cardenosa N; Batalla J; Plasencia A; Salleras L
    Eur J Clin Microbiol Infect Dis; 2006 May; 25(5):310-7. PubMed ID: 16786377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
    Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF
    Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.
    Sun X; Tang F; Hu Y; Deng X; Wang Z; Zhou M; Liu Y
    Hum Vaccin Immunother; 2020 Jul; 16(7):1738-1742. PubMed ID: 31977281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population.
    Plans P
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):961-6. PubMed ID: 23417624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mumps Antibody Titer in MMR-Vaccinated and Vaccine Naïve Children at a Public Hospital in Delhi.
    Saxena B; Ramachandran VG; Saha R; Shah D
    Indian Pediatr; 2021 Feb; 58(2):137-139. PubMed ID: 33632943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evolution of measles, rubella and mumps from the third seroepidemiological survey in the autonomous region of Madrid, Spain].
    Sanz Moreno JC; García Comas L; Ramírez Fernández R; Ramos Blázquez B; Ordobás Gavín M
    Rev Esp Salud Publica; 2009; 83(5):625-37. PubMed ID: 20111811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century.
    Vyse AJ; Gay NJ; Hesketh LM; Pebody R; Morgan-Capner P; Miller E
    Epidemiol Infect; 2006 Dec; 134(6):1303-12. PubMed ID: 16650326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.
    Tharmaphornpilas P; Yoocharean P; Rasdjarmrearnsook AO; Theamboonlers A; Poovorawan Y
    J Health Popul Nutr; 2009 Feb; 27(1):80-6. PubMed ID: 19248651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.